Author

Augusto Chiari

Observed names: A CHIARI, A Chiari, A. CHIARI, A. Chiari

Institution: Nerviano Medical Sciences

Observed institution: Nerviano Medical Sciences

OpenAlex ID: A5047936763

Determination of the Affinity of Drugs toward Serum Albumin by Measurement of the Quenching of the Intrinsic Tryptophan Fluorescence of the Protein

1999 · Dennis E Epps, Thomas J Raub, et al. · Journal of Pharmacy and Pharmacology · 182

Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.

1996 · R Musanti, L Giorgini, et al. · Journal of Lipid Research · 69

N-Imidazolyl-4-chromanones, N-imidazolyl-1-tetralones, and their alcohols as hypolipemic agents raising high-density lipoproteins

1986 · Paolo Cozzi, Umberto Branzoli, et al. · Journal of Medicinal Chemistry · 16

Peritoneal macrophage cholesteryl ester content as a function of plasma cholesterol in rats.

1991 · R Musanti, A Chiari, et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 10

Correction of Dyslipoproteinaemia of Casein-fed Rabbit by Fce 27677, a Potent Novel Acat Inhibitor

1996 · A CHIARI · Pharmacological Research · 8

Effect of the antilipolytic compound acipimox on peroxisome marker enzymes, lipid pattern and biotransformation related functions in rat liver

1985 · Gaetano Orsini, Pier Paolo Lovisolo, et al. · Pharmacological Research Communications · 5

FCE 27677: A novel inhibitor of acyl-CoA:Cholesterol acyltransferase with potent oral hypolipidemic activity

1995 · A CHIARI, P LOVISOLO, et al. · Pharmacological Research · 4

Imidazolylbenzopyrane Derivatives: A New Class Of Acyl-CoA: Cholesterol Acyltranferase (ACAT) Inhibitors

1994 · Daniele Fancelli, Augusto Chiari, et al. · Journal of enzyme inhibition · 4

Synthesis and pharmacological profile of FCE 28654: A water-soluble and injectable ACAT inhibitor

1995 · A. Chiari, D. Fancelli, et al. · Bioorganic & Medicinal Chemistry Letters · 1

ChemInform Abstract: Synthesis and Pharmacological Profile of FCE 28654: A Water‐Soluble and Injectable ACAT Inhibitor.

1995 · A. CHIARI, D. FANCELLI, et al. · ChemInform

Systemic inhibition of acylCoA:cholesterol acyltransferase has lipid-normalizing effect in two hypercholesterolemic rabbit models

1994 · P.P. Lovisolo, A. Chiari, et al. · Atherosclerosis

ChemInform Abstract: Ethyl 2‐((5,6‐Dihydro‐7‐(1H‐imidazol‐1‐yl)‐2‐naphthalenyl)oxy)‐2‐methylpropanoate as a New Potent Oxyisobutyrate Hypolipidemic with Unusual Features.

1987 · P. COZZI, U. BRANZOLI, et al. · ChemInform

Ethyl 2-([5,6-dihydro-7-(1H-imidazol-1-yl)-2-naphthalenyl]oxy)- 2-methylpropanoate as a new potent oxyisobutyrate hypolipidaemic with unusual features.

1987 · P Cozzi, U Branzoli, et al. · PubMed

ChemInform Abstract: N‐Imidazolylchroman‐4‐ones, N‐Imidazolyl‐1‐tetralones, and Their Alcohols as Hypolipemic Agents Raising High‐Density Lipoproteins.

1986 · P. COZZI, U. BRANZOLI, et al. · ChemInform

ChemInform Abstract: ANTILIPOLYTIC ACTIVITY OF NEW PYRAZINE N‐OXIDES. II. (1)

1985 · P. COZZI, A. PILLAN, et al. · ChemInform

Works count: 15

Citation count: 299

H-index: 5

I10-index: 4